Literature DB >> 26339443

An unusual case of iron deficiency anemia is associated with extremely low level of transferrin receptor.

Shuangying Hao1, Huihui Li1, Xiaoyan Sun1, Juan Li2, Kuanyu Li1.   

Abstract

A case study of a female patient, diagnosed with iron deficiency anemia, was unresponsive to oral iron treatment and only partially responsive to parenteral iron therapy, a clinical profile resembling the iron-refractory iron deficiency anemia (IRIDA) disorder. However, the patient failed to exhibit microcytic phenotype, one of the IRIDA hallmarks. Biochemical assays revealed that serum iron, hepcidin, interluekin 6, and transferrin saturation were within the normal range of references or were comparable to her non-anemic offspring. Iron contents in serum and red blood cells and hemoglobin levels were measured, which confirmed the partial improvement of anemia after parenteral iron therapy. Strikingly, serum transferrin receptor in patient was almost undetectable, reflecting the very low activity of bone-marrow erythropoiesis. Our data demonstrate that this is not a case of systemic iron deficiency, but rather cellular iron deficit due to the low level of transferrin receptor, particularly in erythroid tissue.

Entities:  

Keywords:  Iron deficiency anemia; hepcidin; iron therapy; soluble transferrin receptor

Mesh:

Substances:

Year:  2015        PMID: 26339443      PMCID: PMC4555771     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  17 in total

1.  Serum transferrin receptors are decreased in the presence of iron overload.

Authors:  H Khumalo; Z A Gomo; V M Moyo; V R Gordeuk; T Saungweme; T A Rouault; I T Gangaidzo
Journal:  Clin Chem       Date:  1998-01       Impact factor: 8.327

Review 2.  Iron homeostasis.

Authors:  Nancy C Andrews; Paul J Schmidt
Journal:  Annu Rev Physiol       Date:  2007       Impact factor: 19.318

3.  The anemia of "haemoglobin-deficit" (hbd/hbd) mice is caused by a defect in transferrin cycling.

Authors:  An-Sheng Zhang; Alex D Sheftel; Prem Ponka
Journal:  Exp Hematol       Date:  2006-05       Impact factor: 3.084

Review 4.  Structure, function and clinical significance of transferrin receptors.

Authors:  R A Feelders; E P Kuiper-Kramer; H G van Eijk
Journal:  Clin Chem Lab Med       Date:  1999-01       Impact factor: 3.694

5.  Regulation of intracellular iron metabolism in human erythroid precursors by internalized extracellular ferritin.

Authors:  E G Meyron-Holtz; B Vaisman; Z I Cabantchik; E Fibach; T A Rouault; C Hershko; A M Konijn
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

Review 6.  Deferiprone for the treatment of Friedreich's ataxia.

Authors:  Massimo Pandolfo; Laura Hausmann
Journal:  J Neurochem       Date:  2013-08       Impact factor: 5.372

7.  Loss of rapid transferrin receptor recycling due to a mutation in Sec15l1 in hbd mice.

Authors:  Michael D Garrick; Laura M Garrick
Journal:  Biochim Biophys Acta       Date:  2006-10-04

Review 8.  Iron and anemia in human biology: a review of mechanisms.

Authors:  Garry J Handelman; Nathan W Levin
Journal:  Heart Fail Rev       Date:  2008-03-25       Impact factor: 4.214

9.  Acquired iron-deficiency anemia caused by an antibody against the transferrin receptor.

Authors:  J W Larrick; E S Hyman
Journal:  N Engl J Med       Date:  1984-07-26       Impact factor: 91.245

Review 10.  Regional siderosis: a new challenge for iron chelation therapy.

Authors:  Zvi Ioav Cabantchik; Arnold Munnich; Moussa B Youdim; David Devos
Journal:  Front Pharmacol       Date:  2013-12-31       Impact factor: 5.810

View more
  1 in total

1.  Roquin is a major mediator of iron-regulated changes to transferrin receptor-1 mRNA stability.

Authors:  Victor M Corral; Eric R Schultz; Richard S Eisenstein; Gregory J Connell
Journal:  iScience       Date:  2021-03-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.